The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption

Haemophilia

Volumn 19, Issue 6, 2013, Pages 908-912

  Recht, M ^a   Liel, M S ^a,b,e   Turner, R T ^c   Klein, R F ^d   Taylor, J A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

Factor VIII deficiency; Osteopenia; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BETA INTERFERON; CYTOKINE; INTERLEUKIN 1ALPHA; OSTEOCALCIN; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DISEASE; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; HEMOPHILIA A; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; TRABECULAR BONE;

FACTOR VIII DEFICIENCY; OSTEOPENIA; OSTEOPOROSIS;

ANIMALS; BONE DISEASES, METABOLIC; BONE RESORPTION; DISEASE MODELS, ANIMAL; FACTOR VIII; HEMOPHILIA A; INTERFERON-BETA; INTERLEUKIN-1ALPHA; MALE; MICE; MICE, KNOCKOUT; OSTEOCALCIN; OSTEOPROTEGERIN; RANK LIGAND; TIBIA;

EID: 84886641708     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12195     Document Type: Article

References (28)

1. Seeman E. Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities. Am J Med 1993; 95: 22S-8S.
2. Gallacher SJ, Deighan C, Wallace AM et al. Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med 1994; 87: 181-6.
3. Kovacs CS. Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfus Apheres Sci 2008; 38: 33-40.
4. Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis 2006; 1: 108-14.
5. Barnes C, Newall F, Ignjatovic V et al. Reduced bone density in children on long-term warfarin. Pediatr Res 2005; 57: 578-81.
6. Katsarou O, Terpos E, Chatzismalis P et al. Increased bone resportion is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection. Ann Hematol 2010; 89: 67-74.
7. Tlacuilo-Parra A, Villela-Rodriguez J, Garibaldi-Covarrubias R, Soto-Padilla J, Orozco-Alcala J. Bone turnover markers and bone mineral density in children with haemophilia. Haemophilia 2011; 17: 657-61.
8. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
9. Plug I, Van Der Bom JG, Peters M et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006; 4: 510-6.
10. Siboni SM, Mannucci PM, Gringeri A et al., Italian Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-6.
11. Gerstner G, Damiano ML, Tom A et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009; 15: 559-65.
12. Wallny TA, Scholz DT, Oldenburg J et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia 2007; 13: 79-84.
13. Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N, Esparza-Flores MA, Lopez-Guido B, Orozco-Alcala J. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol 2008; 140: 562-7.
14. Donfield SM, Lynn HS, Lail AE et al. Delays in maturation among adolescents with hemophilia and a history of inhibitors. Blood 2007; 110: 3656-61.
15. Liel MS, Greenberg DL, Recht M, Vanek C, Klein RF, Taylor JA. Decreased bone density and bone strength in a mouse model of severe factor VIII deficiency. Br J Haematol 2012; 158: 140-3.
16. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119-21.
17. Bi L, Sarkar R, Naas T et al. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996; 88: 3446-50.
18. Iwaniec UT, Wronski TJ, Turner RT. Histological analysis of bone. Methods Mol Biol 2008; 447: 325-41.
19. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-602.
20. Lee SK, Lorenzo J. Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 2006; 18: 411-8.
21. Peng S, Liu XS, Huang S et al. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Bone 2011; 49: 1290-8.
22. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20: 345-57.
23. Christoforidis A, Economou M, Papadopoulou E et al. Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia. Haemophilia 2011; 17: e217-22.
24. Schett G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011; 41: 1361-6.
25. Naldini A, Pucci A, Carney DH, Fanetti G, Carraro F. Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1. Cytokine 2002; 20: 191-9.
26. Fan Y, Zhang W, Mulholland M. Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells. J Surg Res 2005; 129: 196-201.
27. Pagel CN, Song SJ, Loh LH et al. Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids. Bone 2009; 44: 813-21.
28. Abraham AK, Ramanathan M, Weinstock-Guttman B, Mager DE. Mechanisms of interferon-beta effects on bone homeostasis. Biochem Pharmacol 2009; 77: 1757-62.